Pharmacological studies of voltage-sensitive Ca2+-channels involved in the release of vasoactive intestinal peptide evoked by K+ in mouse cerebral cortical slices

J. L. Martin, Pierre Magistretti*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

18 Scopus citations

Abstract

Three types of voltage-sensitive Ca2+-channels, denominated T, N and L, have recently been identified in the nervous system. This classification is based on both the electrophysiological and pharmacological properties of each type of channel. The increase in free intracellular Ca2+ concentration that results from the opening of voltage-sensitive Ca2+-channels triggers various cellular processes. One such process is the depolarization-induced release of neurotransmitters. Owing to the rather selective sensitivity of each type of voltage-sensitive Ca2+-channel to certain antagonists, attempts have recently been carried out to determine which of the T, N or L channels mediates neurotransmitter release. In the present study we have applied such a strategy to the study of the release of vasoactive intestinal peptide from mouse cerebral cortical slices. The release of vasoactive intestinal peptide evoked by K+ 20 mM is inhibited in a concentration-dependent manner by Co2+, Ni2+ and Mn2+ while it remains unaffected by diltiazem 20μM, nifedipine 10μM, ω-conotoxin 1 μM and Cd2+ up to 100μM. Such a pharmacological profile indicates that voltage-sensitive Ca2+-channels of the N and L types are not involved in the release of vasoactive intestinal peptide. These observations are in contrast to what has been described for amine release in the central nervous system, which appears to be mediated by voltage-sensitive Ca2+-channels of the N type. Other pharmacological characteristics of the K+-evoked release of vasoactive intestinal peptide are as follows: it is insensitive to tetrodotoxin (2 μM) and it is enhanced by K+-channel blockers such as Cs+ (1 mM), Ba2+ (1 mM) and tetraethylammonium (10 mM). In addition to K+, veratridine, an Na+-channel agonist, and ouabain, a blocker of the Na+/K+-ATPase, promote the release of vasoactive intestinal peptide (18-and 4-fold increase over basal level for veratridine 50 μM and ouabain 100/μM respectively). The release of vasoactive intestinal peptide evoked by veratridine 50 μM is completely blocked by tetrodotoxin 2 μM, whereas the stimulatory effect of ouabain is inhibited in a concentration-dependent manner (between 0.1 and 5mM) by amiloride, a blocker of the Na+/H+ exchange system.

Original languageEnglish (US)
Pages (from-to)423-431
Number of pages9
JournalNeuroscience
Volume30
Issue number2
DOIs
StatePublished - Jan 1 1989

ASJC Scopus subject areas

  • Neuroscience(all)

Fingerprint

Dive into the research topics of 'Pharmacological studies of voltage-sensitive Ca<sup>2+</sup>-channels involved in the release of vasoactive intestinal peptide evoked by K<sup>+</sup> in mouse cerebral cortical slices'. Together they form a unique fingerprint.

Cite this